Identification of Tumor-Specific MRI Biomarkers Using Machine Learning (ML)

Area of Science:

• Oncology
• Biomarker Discovery
• Medical Imaging
• Machine Learning

Background:

• Reliable and non-invasive oncology biomarkers are essential for effective cancer diagnosis and management.
• Current approved cancer biomarkers often lack high specificity, necessitating improved diagnostic tools.
• Advancements in machine learning (ML) and artificial intelligence (AI) offer new avenues for identifying predictive biomarkers.

Purpose of the Study:

• To summarize the current state of developing and applying Magnetic Resonance Imaging (MRI) biomarkers in oncology.
• To explore the potential of ML/AI in creating highly predictive and disease-specific MRI biomarkers.
• To detail the entire pipeline of MRI biomarker development, from data collection to clinical application.

Main Methods:

• Review of current literature on MRI biomarker development in cancer care.
• Focus on data collection, preprocessing techniques, and ML/AI methodologies for biomarker identification.
• Categorization of existing MRI biomarkers and their clinical utility across various cancer types.

Main Results:

• ML/AI techniques are enabling the discovery of highly predictive and specific biomarkers from MRI data.
• These novel biomarkers show promise for cancer diagnosis, prognosis prediction, and treatment efficacy assessment.
• A comprehensive overview of MRI biomarker applications in diverse oncological settings is presented.

Conclusions:

• MRI biomarkers, particularly those developed using ML/AI, represent a significant advancement in oncology.
• These biomarkers have the potential to revolutionize cancer diagnosis, patient stratification, and treatment monitoring.
• Further research and validation are ongoing to integrate these advanced biomarkers into routine clinical practice.